BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17335006)

  • 1. Identifying long-range structure in the intrinsically unstructured transactivation domain of p53.
    Vise P; Baral B; Stancik A; Lowry DF; Daughdrill GW
    Proteins; 2007 May; 67(3):526-30. PubMed ID: 17335006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the accessible conformations of the intrinsically unstructured transactivation domain of p53.
    Lowry DF; Stancik A; Shrestha RM; Daughdrill GW
    Proteins; 2008 May; 71(2):587-98. PubMed ID: 17972286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive binding between dynamic p53 transactivation subdomains to human MDM2 protein: implications for regulating the p53·MDM2/MDMX interaction.
    Shan B; Li DW; Brüschweiler-Li L; Brüschweiler R
    J Biol Chem; 2012 Aug; 287(36):30376-84. PubMed ID: 22807444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A second p53 binding site in the central domain of Mdm2 is essential for p53 ubiquitination.
    Ma J; Martin JD; Zhang H; Auger KR; Ho TF; Kirkpatrick RB; Grooms MH; Johanson KO; Tummino PJ; Copeland RA; Lai Z
    Biochemistry; 2006 Aug; 45(30):9238-45. PubMed ID: 16866370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-expression of the human MDM2 p53 binding domain by fusion to a p53 transactivation peptide.
    Liu Z; Olejniczak ET; Fesik SW
    Protein Expr Purif; 2004 Oct; 37(2):493-8. PubMed ID: 15358376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the K24N mutation on the transactivation domain of p53 and its binding to murine double-minute clone 2.
    Zhan YA; Wu H; Powell AT; Daughdrill GW; Ytreberg FM
    Proteins; 2013 Oct; 81(10):1738-47. PubMed ID: 23609977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural details on mdm2-p53 interaction.
    Chi SW; Lee SH; Kim DH; Ahn MJ; Kim JS; Woo JY; Torizawa T; Kainosho M; Han KH
    J Biol Chem; 2005 Nov; 280(46):38795-802. PubMed ID: 16159876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-site regulation of MDM2 E3-ubiquitin ligase activity.
    Wallace M; Worrall E; Pettersson S; Hupp TR; Ball KL
    Mol Cell; 2006 Jul; 23(2):251-63. PubMed ID: 16857591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding induced folding in p53-MDM2 complex.
    Chen HF; Luo R
    J Am Chem Soc; 2007 Mar; 129(10):2930-7. PubMed ID: 17302414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MDM2-binding region in the transactivation domain of p53 also acts as a Bcl-X(L)-binding motif.
    Xu H; Ye H; Osman NE; Sadler K; Won EY; Chi SW; Yoon HS
    Biochemistry; 2009 Dec; 48(51):12159-68. PubMed ID: 19916559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitination of p53 at multiple sites in the DNA-binding domain.
    Chan WM; Mak MC; Fung TK; Lau A; Siu WY; Poon RY
    Mol Cancer Res; 2006 Jan; 4(1):15-25. PubMed ID: 16446403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-range modulation of chain motions within the intrinsically disordered transactivation domain of tumor suppressor p53.
    Lum JK; Neuweiler H; Fersht AR
    J Am Chem Soc; 2012 Jan; 134(3):1617-22. PubMed ID: 22176582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural divergence is more extensive than sequence divergence for a family of intrinsically disordered proteins.
    Borcherds W; Kashtanov S; Wu H; Daughdrill GW
    Proteins; 2013 Oct; 81(10):1686-98. PubMed ID: 23606624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the p53-MDM2 interaction by phosphorylation of Thr18: a computational study.
    Lee HJ; Srinivasan D; Coomber D; Lane DP; Verma CS
    Cell Cycle; 2007 Nov; 6(21):2604-11. PubMed ID: 17957142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53.
    Teufel DP; Freund SM; Bycroft M; Fersht AR
    Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7009-14. PubMed ID: 17438265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative lid dynamics of MDM2 reveals differential ligand binding modes of the p53-binding cleft.
    Showalter SA; Bruschweiler-Li L; Johnson E; Zhang F; Brüschweiler R
    J Am Chem Soc; 2008 May; 130(20):6472-8. PubMed ID: 18435534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100 proteins interact with the N-terminal domain of MDM2.
    van Dieck J; Lum JK; Teufel DP; Fersht AR
    FEBS Lett; 2010 Aug; 584(15):3269-74. PubMed ID: 20591429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Mechanism of p53 Rescue by SUSP4.
    Kim DH; Lee C; Lee SH; Kim KT; Han JJ; Cha EJ; Lim JE; Cho YJ; Hong SH; Han KH
    Angew Chem Int Ed Engl; 2017 Jan; 56(5):1278-1282. PubMed ID: 28000315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic and thermodynamic effects of phosphorylation on p53 binding to MDM2.
    Yadahalli S; Neira JL; Johnson CM; Tan YS; Rowling PJE; Chattopadhyay A; Verma CS; Itzhaki LS
    Sci Rep; 2019 Jan; 9(1):693. PubMed ID: 30679555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatic-aromatic interactions in the formation of the MDM2-p53 complex.
    Espinoza-Fonseca LM; García-Machorro J
    Biochem Biophys Res Commun; 2008 Jun; 370(4):547-51. PubMed ID: 18355443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.